Shows & Panels
- Accelerate and Streamline for Better Customer Service
- Ask the CIO
- The Big Data Dilemma
- Carrying On with Continuity of Operations
- Client Virtualization Solutions
- Data Protection in a Virtual World
- Expert Voices
- Federal Executive Forum
- Federal IT Challenge
- Federal Tech Talk
- Feds in the Cloud
- Health IT: A Policy Change Agent
- Improving Healthcare Outcomes through IT Policy
- IT Innovation in the New Era of Government
- Making Dollars And Sense Out of Data Center Consolidation
- Navigating the Private Cloud
- One Step to the Cloud, Two Steps Toward Innovation
- Path to FDCCI Compliance
- Take Command of Your Mobility Initiative
Shows & Panels
Mass. girl, parents awarded $63M in Motrin lawsuit
Wednesday - 2/13/2013, 7:40pm EST
BOSTON (AP) -- Health care company Johnson & Johnson has been told to pay a teenager and her parents $63 million after she suffered a life-threatening drug reaction and lost most of her skin when she took a children's pain reliever nearly a decade ago.
Johnson & Johnson and its McNeil-PPC Inc. subsidiary should pay Samantha Reckis and her parents a total of $109 million, including interest, a Plymouth Superior Court jury decided on Wednesday.
Samantha was 7 when she was given Motrin brand ibuprofen, family attorney Brad Henry said. She suffered a rare side effect known as toxic epidermal necrolysis and lost 90 percent of her skin and was blinded, he said.
She suffered brain damage that "thankfully" involved only short-term memory loss, he said, and surgeons had to drill through her skull to relieve some pressure.
The disease also seared Samantha's respiratory system, and she now has just 20 percent lung capacity, Henry said.
The family filed the lawsuit in January 2007, claiming that Samantha was blinded by Motrin and alleging that Johnson & Johnson failed to warn consumers that the drug could cause life-threatening reactions. The five-week trial ended on Wednesday when the jury awarded $50 million in compensatory damages to Samantha and $6.5 million to each of her parents.
Samantha, now 16 years old, had previously taken Motrin without suffering any side effects. Her parents began giving her the medication to reduce fever that began the day after Thanksgiving in 2003. The resulting toxic epidermal necrolysis -- a potentially fatal skin disease that inflames the mucus membranes and eyes and is marked by a rash that burns off the outer layer of skin -- puzzled physicians. It inflamed Samantha's throat, mouth, eyes, esophagus, intestinal tract, respiratory system and reproductive system, forcing physicians to put her in a coma.
The McNeil unit of Johnson & Johnson Services Inc., which is based in New Brunswick, N.J., said it disagreed with the verdict and was considering additional legal options.
"The Reckis family has suffered a tragedy, and we sympathize deeply with them," it said in a statement.
But the firm sought to defend Children's Motrin, saying it is "labeled appropriately" and when used as directed is "a safe and effective treatment option for minor aches and pains and fever."
"A number of medicines, including ibuprofen, have been associated with allergic reactions and as noted on the label, consumers should stop using medications and immediately contact a healthcare professional if they have an allergic reaction," it said in the statement.
Samantha, who lives in Plymouth, is an honor student but has to work twice as hard as other students to retain the same amount of information, Henry said. She doesn't want to let her plight hold her down, he said.
In a similar case in Pennsylvania, a girl was awarded $10 million in 2011 after an adverse reaction to Children's Motrin caused her to lose 84 percent of her skin, suffer brain damage and go blind.
Associated Press writer Denise Lavoie contributed to this report.
Rodrique Ngowi can be reached at http://www.twitter.com/ngowi
Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.